LDS/Medical Tests/N-Acetyltransferase 2 (NAT2) Gene Mutation Analysis

N-Acetyltransferase 2 (NAT2) Gene Mutation Analysis

Isosorbidedinitrate and hydralazine hydrochloride (Bidil), isoniazid, procainamide, dapsone, nitrazepam, hydralazine, and zonisamide are metabolized by NAT2, and individuals who are “fast acetylators” may have increased exposure to these drugs, whereas individuals who are “slow acetylators” may have increased drug bioavailability. Acetylation status of an individual can be determined by examining genetic variants in the NAT2 gene.

The NAT2 gene has a high frequency of functional variation, differing amongst populations that are ethnically diverse, and has high levels of haplotype diversity. SNPs within the NAT2 gene may cause reduced enzyme stability, altered substrate affinity, or a protein product that is targeted for degradation. NAT1 alleles result in a phenotype equivalent to that of reference NAT1*4 (*20, *21, *23, *24, *25, *27), some confer a "slow" acetylation phenotype (*5, *6, *7, *14A, *14B, *17, *22), or result in truncated proteins with no enzymatic activity (*15, *19A, *19B), and others are undetermined. NAT2 genotypes can be grouped into three different phenotypes: “slow acetylator” (two slow alleles), “intermediate acetylator” (1 slow and 1 rapid allele), and “rapid acetylator” (2 rapid alleles, sometimes referred to as “fast”).

  • Identifying patients who may require drug dosing adjustments for procainamide, dapsone, nitrazepam, hydralazine, zonisamide, and isoniazid
  • Individuals are classified as being slow, intermediate, or fast acetylators depending on their diplotypes. Slow acetylators have two “slow” haplotypes, fast acetylators have two “fast” haplotypes, and intermediate acetylators have one of each
  • Slow acetylators should be monitored for signs of toxicity
  • Dose reductions may be considered for both slow and intermediate acetylators

\*4/\*4.

Polymerase chain reaction (PCR) followed by DNA sequence analysis; Allele-specific PCR.

Whole blood, saliva, or buccal swab

Blood collected in lavender top tube (EDTA) or any anticoagulant collection devices.

Stability

  • Ambient: 5 days
  • Refrigerated: 7 days
CYP450 genotyping (CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP3A5).
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login